Yosuke Shimizu

8PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersHaematological tumoursPharmaceutical delivery technologiesMedical mycologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 10, 2026
Evolving Variants, Shifting Outcomes: Implications for Nonconcurrent Controls in Platform Trials for COVID-19.

|Feb 21, 2025
LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

Nobumasa Okumura, Eriko Morino, Hidetoshi Nomoto

|Nov 22, 2024
Planning and Implementing Master Protocol Trials in Japan: Key Considerations of the Japanese Guideline.

Akihiro Hirakawa, Takashi Asakawa, Kota Tokushige

|Nov 14, 2023
Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.

Naokatsu Ando, Daisuke Mizushima, Yosuke Shimizu

|Aug 25, 2023
Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.

Rina Yano, Junko Terada-Hirashima, Yukari Uemura

|Aug 10, 2023
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.

Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura

Pageof 2

Frequent Collaborators

4 joint publications

Yukari Uemura

3 joint publications

Mugen Ujiie

3 joint publications

Nobumasa Okumura

2 joint publications

Tetsuya Suzuki